Skip to content

NA 75100844Recalls & reported problems

Smith & Nephew, Inc. · TRIAL FEMORAL HEAD 28 S/+0 · Class 2

Adverse event reports
6
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 07611996121773), received between Mar 7, 2021 and Apr 5, 2026 — classified as 6 malfunctions.

The most frequently reported specific device problem is “Break” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 1 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break3
  • Fracture2
  • Crack1

Patient problems

  • No Clinical Signs, Symptoms or Conditions6

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 5, 2026Break

    IT WAS REPORTED THAT, DURING A THA SURGERY, THE HIP WAS TOO TIGHT AND, WHEN AN ATTEMPT TO REDUCE IT WAS MADE, ONE (1) TRIAL FEMORAL HEAD 28 S/+0 BROKE WHILE TRYING TO REMOVE IT. THE PROCEDURE WAS RESUMED, WITHOUT ANY DELAY, USING AN EQUIVALENT S+N BACK-UP. NO FURTHER COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24786977 ↗
  • MalfunctionApr 25, 2024Break; Break

    IT WAS REPORTED THAT, DURING A THR SURGERY, THE TRIAL FEMORAL HEAD 28 S/+0 BROKE WHILE TRIALING. IT IS UNKNOWN HOW THE SURGERY WAS COMPLETED OR IF THIS CAUSED A SURGICAL DELAY. NO INJURIES WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19183307 ↗
  • MalfunctionFeb 5, 2023Fracture; Fracture

    IT WAS REPORTED THAT, DURING A THR SURGERY, THE INTERNAL FLAP OF THE TRIAL FEMORAL HEAD 28 S/+0 DEVICE THAT SNAPS ONTO STEM, WAS FOUND TO BE FRACTURED. NO PIECES FELL INTO PATIENT. THE PROCEDURE WAS RESUMED, WITHOUT ANY DELAY, USING A S+N BACK-UP DEVICE. PATIENT WAS NOT INJURED AS CONSEQUENCE OF THIS PROBLEM.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16302049 ↗
  • MalfunctionJun 2, 2022Break; Break

    IT WAS REPORTED THAT THE TRIAL FEMORAL HEAD 28 S/+0 BROKE. AS THIS WAS NOTICED AFTER SURGERY, THE PATIENT WAS NO LONGER INVOLVED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14580891 ↗
  • MalfunctionJul 21, 2021Crack; Crack

    IT WAS REPORTED THAT A TRIAL FEMORAL HEAD 28 S/+0 HAS A CRACK ON TOP OF THE HEAD TRIAL. NO PATIENT INVOLVED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12203036 ↗
  • MalfunctionMar 7, 2021Fracture; Fracture

    IT WAS REPORTED THAT DURING A EFIP INSPECTION, THE TRIAL FEMORAL HEAD 28 S/+0 WAS FOUND WITH A FLAP BROKEN.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11429684 ↗

Other Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented devices

All Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.